No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs539307315 |
chr22:29874525-29874526 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs557373019 |
chr22:29874534-29874535 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs59221441 |
chr22:29874680-29874681 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs466679 |
chr22:29874695-29874696 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs572502749 |
chr22:29874728-29874729 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs539983648 |
chr22:29874741-29874742 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs371184016 |
chr22:29874755-29874756 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs165823 |
chr22:29874756-29874757 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs542433005 |
chr22:29874759-29874760 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs563828633 |
chr22:29874767-29874768 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs536452563 |
chr22:29874772-29874773 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs531243198 |
chr22:29874776-29874777 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs201924016 |
chr22:29874794-29874795 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs190973562 |
chr22:29874814-29874815 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs541782332 |
chr22:29874838-29874839 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs564497181 |
chr22:29874872-29874873 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs528470289 |
chr22:29874875-29874876 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs184019772 |
chr22:29874916-29874917 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs568561918 |
chr22:29874923-29874924 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs187216344 |
chr22:29874970-29874971 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs550370501 |
chr22:29874993-29874994 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs568700790 |
chr22:29874998-29874999 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs191641888 |
chr22:29875048-29875049 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs557610349 |
chr22:29875052-29875053 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs145191558 |
chr22:29875059-29875060 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs571035747 |
chr22:29875063-29875064 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs533800479 |
chr22:29875121-29875122 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs527345556 |
chr22:29875125-29875126 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs555036991 |
chr22:29875143-29875144 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs540868856 |
chr22:29875154-29875155 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs148912863 |
chr22:29875176-29875177 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs544286487 |
chr22:29875202-29875203 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs183087493 |
chr22:29875266-29875267 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs554787034 |
chr22:29875277-29875278 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs78131720 |
chr22:29875315-29875316 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs546552216 |
chr22:29875317-29875318 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs564783214 |
chr22:29875335-29875336 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs539373166 |
chr22:29875353-29875354 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs116238994 |
chr22:29875413-29875414 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs59206935 |
chr22:29875443-29875444 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs529428258 |
chr22:29875473-29875474 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs550658968 |
chr22:29875519-29875520 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs112036791 |
chr22:29875579-29875580 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs113906067 |
chr22:29875606-29875607 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs554700762 |
chr22:29875612-29875613 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs190153690 |
chr22:29875659-29875660 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs551127456 |
chr22:29875684-29875685 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs566783550 |
chr22:29875725-29875726 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs563936478 |
chr22:29875727-29875728 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs533800960 |
chr22:29875733-29875734 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|